Dennis Podlesak, Director at Syndax Pharmaceuticals Inc (SNDX), sold 57,600 shares at $15.84 ($875K) on 2025-08-18, disclosed to the SEC on 2025-08-18.
Scheduled sale ($875k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.19 | 19,200 | $272K | 31.1% |
| 2 | $15.54 | 19,200 | $298K | 34.1% |
| 3 | $15.84 | 19,200 | $304K | 34.8% |
| Total | $15.19 avg | 57,600 | $875K | 100% |
| Filing → |
| AVNR | BUY | 2006-06-02 | $10K | — | Filing → |